Avance Clinical partners with four Taiwanese trial sites

Avance Clinical has signed four Memorandums of Understanding (MOUs) with major clinical trial sites in Taiwan, marking its expansion into the region. This move aims to enhance access for U.S. biotech companies to high-quality clinical research services in Asia. The new partnerships include Taichung Veterans General Hospital, Taipei Medical University, China Medical University Hospital, and Kaohsiung Medical University Chung-Ho Memorial Hospital. These institutions are recognized for their advanced healthcare capabilities and will support efficient clinical trials. Avance Clinical's expansion into Taiwan is expected to streamline access to clinical trial resources and regulatory pathways, benefiting biotech sponsors and improving patient access to innovative treatments.